ARTICLE | Politics, Policy & Law
Revamped Senate stimulus bill would provide $27B to HHS to combat pandemic
BioCentury is providing this story for free given the urgent need for information about the COVID-19 crisis. For more analysis, sign up for our daily email.
March 26, 2020 1:10 AM UTC
The U.S. Senate’s latest COVID-19 stimulus bill would appropriate $340 billion to support local and national agencies to combat the pandemic, including billions for biopharma R&D.
HHS’s Public Health and Social Services Emergency Fund would receive $27 billion in funding to develop countermeasures and vaccines, with platform technologies with U.S.-based manufacturing capabilities given priority, according to a version of the Coronavirus Aid, Relief, and Economic Security (CARES) Act released by Sen. Patrick Leahy (D-Vt.), vice chairman of the Senate Appropriations Committee...